IL158433A0 - Toluene sulfonamide-containing anti-tumor composition and method of use thereof - Google Patents
Toluene sulfonamide-containing anti-tumor composition and method of use thereofInfo
- Publication number
- IL158433A0 IL158433A0 IL15843302A IL15843302A IL158433A0 IL 158433 A0 IL158433 A0 IL 158433A0 IL 15843302 A IL15843302 A IL 15843302A IL 15843302 A IL15843302 A IL 15843302A IL 158433 A0 IL158433 A0 IL 158433A0
- Authority
- IL
- Israel
- Prior art keywords
- toluene sulfonamide
- containing anti
- compositions
- tumor composition
- tumor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/835,908 US6727287B2 (en) | 2001-04-16 | 2001-04-16 | Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
| PCT/US2002/011786 WO2002083117A1 (en) | 2001-04-16 | 2002-04-16 | Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL158433A0 true IL158433A0 (en) | 2004-05-12 |
Family
ID=25270767
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15843302A IL158433A0 (en) | 2001-04-16 | 2002-04-16 | Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
| IL158433A IL158433A (en) | 2001-04-16 | 2003-10-15 | Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL158433A IL158433A (en) | 2001-04-16 | 2003-10-15 | Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6727287B2 (ru) |
| EP (1) | EP1389101B1 (ru) |
| JP (1) | JP2004526760A (ru) |
| CN (1) | CN100471491C (ru) |
| AT (1) | ATE415960T1 (ru) |
| AU (1) | AU2002303350B2 (ru) |
| BR (1) | BR0208961A (ru) |
| CA (1) | CA2444842A1 (ru) |
| DE (1) | DE60230133D1 (ru) |
| EA (1) | EA007685B1 (ru) |
| ES (1) | ES2316565T3 (ru) |
| HK (1) | HK1067545A1 (ru) |
| IL (2) | IL158433A0 (ru) |
| MX (1) | MXPA03009483A (ru) |
| NZ (1) | NZ529513A (ru) |
| WO (1) | WO2002083117A1 (ru) |
| ZA (1) | ZA200308814B (ru) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005005397B4 (de) * | 2005-02-05 | 2008-08-21 | Lts Lohmann Therapie-Systeme Ag | Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms |
| US7790928B1 (en) * | 2005-04-25 | 2010-09-07 | Albert Raymond Hechinger | Therapeutic dimethyl sulfoxide (aka DMSO) compositions and methods of use |
| WO2007076875A2 (en) * | 2006-01-06 | 2007-07-12 | Aarhus Universitet | Compounds acting on the serotonin transporter |
| CN104473914B (zh) * | 2015-01-06 | 2017-01-11 | 天津红日药业股份有限公司 | 一种磺酰胺类药物组合物 |
| US10465742B2 (en) | 2015-10-29 | 2019-11-05 | Inteva Products, Llc | Cable end fitting and cable abutment and method of securement |
| US9782370B2 (en) * | 2015-12-21 | 2017-10-10 | Gongwin Biopharm Holdings Co., Ltd. | Pharmaceutical compositions of benzenesulfonamide derivatives for treatment of adenoid cystic carcinoma |
| US10182998B2 (en) * | 2016-06-10 | 2019-01-22 | Gongwin Biopharm Holdings Co., Ltd. | Benzenesulfonamide compositions for treatment of malignant pleural effusions |
| US9668990B1 (en) | 2016-06-10 | 2017-06-06 | Gongwin Biopharm Holdings Co., Ltd. | Benzenesulfonamides compositions for treatment of malignant pleural effusions |
| US20180055796A1 (en) * | 2016-08-23 | 2018-03-01 | Gongwin Biopharm Holdings Co., Ltd. | Pharmaceutical composition exhibiting anti-tumor activity, method for treating patient suffering from cancer and method for inhibiting tumor growth |
| US20200338028A1 (en) * | 2017-12-29 | 2020-10-29 | Gongwin Biopharm Co., Ltd. | Benzenesulfonamide derivatives and method for modulating lipid raft |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3340148A (en) | 1961-03-22 | 1967-09-05 | Gillette Inhibitor Co | Treatment of fungus diseases of the skin |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4160452A (en) | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US4777049A (en) | 1983-12-01 | 1988-10-11 | Alza Corporation | Constant release system with pulsed release |
| US4663308A (en) | 1984-07-18 | 1987-05-05 | Medical College Of Ohio | Method of use of polymers containing cross-linked azo bonds for releasing therapeutic agents into the lower gastrointestinal tract |
| US4983396A (en) | 1985-12-06 | 1991-01-08 | Key Pharmaceuticals, Inc. | Percutaneous penetration enhancer of oleic acid and 2-ethyl-1,3-hexanediol |
| US4764381A (en) | 1985-12-06 | 1988-08-16 | Key Pharmaceuticals, Inc. | Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol |
| US5891454A (en) | 1997-03-28 | 1999-04-06 | Alexander Wu | Anti-cancer drug and special tumor necrotizing agent |
| CN1073415C (zh) | 1997-07-03 | 2001-10-24 | 吴宜庄 | 磺酰胺类化合物在制备抗癌药物中的应用 |
-
2001
- 2001-04-16 US US09/835,908 patent/US6727287B2/en not_active Expired - Lifetime
-
2002
- 2002-04-16 NZ NZ529513A patent/NZ529513A/en not_active IP Right Cessation
- 2002-04-16 AU AU2002303350A patent/AU2002303350B2/en not_active Ceased
- 2002-04-16 EP EP02731370A patent/EP1389101B1/en not_active Expired - Lifetime
- 2002-04-16 ES ES02731370T patent/ES2316565T3/es not_active Expired - Lifetime
- 2002-04-16 JP JP2002580921A patent/JP2004526760A/ja not_active Withdrawn
- 2002-04-16 AT AT02731370T patent/ATE415960T1/de not_active IP Right Cessation
- 2002-04-16 DE DE60230133T patent/DE60230133D1/de not_active Expired - Lifetime
- 2002-04-16 CN CNB028106393A patent/CN100471491C/zh not_active Expired - Fee Related
- 2002-04-16 IL IL15843302A patent/IL158433A0/xx unknown
- 2002-04-16 WO PCT/US2002/011786 patent/WO2002083117A1/en active IP Right Grant
- 2002-04-16 CA CA002444842A patent/CA2444842A1/en not_active Abandoned
- 2002-04-16 EA EA200301126A patent/EA007685B1/ru not_active IP Right Cessation
- 2002-04-16 MX MXPA03009483A patent/MXPA03009483A/es active IP Right Grant
- 2002-04-16 BR BR0208961-0A patent/BR0208961A/pt not_active Application Discontinuation
-
2003
- 2003-10-15 IL IL158433A patent/IL158433A/en not_active IP Right Cessation
- 2003-11-12 ZA ZA200308814A patent/ZA200308814B/en unknown
-
2004
- 2004-12-30 HK HK04110325.1A patent/HK1067545A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2444842A1 (en) | 2002-10-24 |
| EP1389101A4 (en) | 2005-05-04 |
| ATE415960T1 (de) | 2008-12-15 |
| DE60230133D1 (de) | 2009-01-15 |
| ES2316565T3 (es) | 2009-04-16 |
| IL158433A (en) | 2010-11-30 |
| US20030022843A1 (en) | 2003-01-30 |
| ZA200308814B (en) | 2004-11-23 |
| EA007685B1 (ru) | 2006-12-29 |
| JP2004526760A (ja) | 2004-09-02 |
| HK1067545A1 (en) | 2005-04-15 |
| CN1511032A (zh) | 2004-07-07 |
| NZ529513A (en) | 2005-10-28 |
| CN100471491C (zh) | 2009-03-25 |
| MXPA03009483A (es) | 2004-12-06 |
| BR0208961A (pt) | 2005-02-01 |
| US6727287B2 (en) | 2004-04-27 |
| EP1389101B1 (en) | 2008-12-03 |
| EP1389101A1 (en) | 2004-02-18 |
| WO2002083117A1 (en) | 2002-10-24 |
| AU2002303350B2 (en) | 2007-08-02 |
| EA200301126A1 (ru) | 2004-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002319814A1 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
| MXPA01007451A (es) | Porfirinas sustituidas. | |
| AP9901478A0 (en) | Compounds for the treatment of ischemia. | |
| ATE238307T1 (de) | Substituierte porphyrinen | |
| IL140710A0 (en) | Pulmonary delivery of active agents | |
| MXPA02012817A (es) | Drogas antineoplasicas liposomales y uso de las mismas. | |
| MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
| YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
| DE69928655D1 (de) | Substituierte porphyrine | |
| CA2337991A1 (en) | Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents | |
| UA66865C2 (ru) | Инденопирролокарбазолы, фармацевтическая композиция, способ ингибирования киназной активности и способ лечения (варианты) | |
| WO2003103581A3 (en) | COMPOSITIONS AND METHODS FOR LIVER GROWTH AND PROTECTION | |
| IL153680A0 (en) | Aplidine derivatives and methods for the preparation thereof | |
| DE60021381D1 (de) | Chinonverbindungen zur behandlung von krankheiten | |
| WO2000018439A3 (de) | Verwendung von neoangiogenese-markern für diagnose und therapie von tumoren | |
| YU13301A (sh) | Muskarinski agonisti i antagonisti | |
| IL158433A (en) | Toluene sulfonamide-containing anti-tumor composition and method of use thereof | |
| DK1056704T3 (da) | Antitumormidler | |
| SE9802937D0 (sv) | Novel compounds | |
| AU2002350623A1 (en) | Targeted thrombosis by tissue factor polypeptides | |
| MY134019A (en) | Aryl oxime-piperazines useful as ccr5 antagonists | |
| AU2001233912A1 (en) | Diagnosis of breast cancer using bcmp-81 as marker | |
| ATE476987T1 (de) | Zusammensetzungen und methoden zur behandlung von candidosen | |
| MXPA03010737A (es) | Aril-8-azabiciclo(3.2.1) octanos para tratamiento de depresion. | |
| EP1436279B8 (en) | Chemical compounds |